Efficacy and safety of nimotuzumab combined with chemoradiotherapy in the treatment of locally advanced cervical cancer.

Annals of translational medicine(2022)

Cited 1|Views10
No score
Abstract
Nimotuzumab combined with CCRT enhanced the PFS and CRR of LACC patients and was well tolerated. The results can provide reference for clinical treatment of LACC.
More
Translated text
Key words
Nimotuzumab,adverse events (AEs),concurrent chemoradiotherapy (CCRT),locally advanced cervical cancer (LACC)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined